Ad
related to: rifaximin antibiotics classification
Search results
Results From The WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
A07AA11 Rifaximin A07AA12 Fidaxomicin A07AA13 Rifamycin A07AA51 Neomycin, combinations A07AA54 Streptomycin, combinations QA07AA90 Dihydrostreptomycin QA07AA91 Gentamicin QA07AA92 Apramycin QA07AA93 Bacitracin QA07AA94 Enramycin QA07AA95 Avilamycin QA07AA96 Bambermycin QA07AA98 Colistin, combinations with other antibacterials QA07AA99 ...
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
However, these classifications are based on laboratory behavior. The development of antibiotics has had a profound effect on the health of people for many years. Also, both people and animals have used antibiotics to treat infections and diseases. In practice, both treat bacterial infections. [1]
A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study.. The antibiotic, rifaximin, has enabled the global ...
Category: Rifamycin antibiotics. 15 languages. ... Rifaximin This page was last edited on 22 July 2017, at 03:01 (UTC). Text is available under the Creative ...
ATC code J01 Antibacterials for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
ATC code D06 Antibiotics and chemotherapeutics for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.